Position in AXGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$49,053
+$15,526 QoQ
Shares Held
1,062
+4.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#207
of 252 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AXGN Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026MCF Advisors LLC holds $2,022,585 across 21 Medical Devices names. AXGN ranks #6 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
7,389 | $670,477 | |
| 2 | SYK |
Stryker Corp
|
1,373 | $432,275 | |
| 3 | TXG |
10x Genomics, Inc.
|
6,431 | $246,564 | |
| 4 | MDT |
Medtronic plc
|
2,660 | $208,091 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
2,834 | $181,404 | |
| 6 | AXGN |
Axogen, Inc.
This page
|
1,062 | $49,053 | |
| 7 | EW |
Edwards Lifesciences Corp
|
364 | $32,927 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
380 | $32,714 |
All Filings in AXGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,053 | 1,062 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $33,527 | 1,012 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $29,817 | 911 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||